Atlas Trials

A Study on Cytomegalovirus (CMV) Infection Outcomes Among Hematopoietic Stem Cell Transplant (HSCT) Participants in Europe and Canada

Clinical trial NCT05571137 · COMPLETED

Trial details

NCT number
NCT05571137
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Cytomegalovirus (CMV)
Start date
2023-05-31
Primary completion
2024-01-31
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.